Priceline.Com Inc (PCLN) 1,158.41 $PCLN Public

New Post Public Reply Private Reply Replies (0) Message Board

Mar 16, 2015 at 2:10 PM

Priceline.Com Inc (PCLN) 1,158.41 $PCLN

Public CoverGirl? P&G Said To Explore Beautiful IPO
at Investor's Business Daily - 26 mins ago
Procter & Gamble (PG) is said to be exploring a potential sale or initial public offering of some of its beauty brands, said Bloomberg News. Shares were still up 1.8% in early afternoon trading following the news in the stock market today, Monday....
PFE: 34.46 (+0.46), PG: 83.29 (+1.46), AAPL: 124.24 (+0.65), PCLN: 1,158.41 (+0.64)

Priceline Deserves A Higher Price: Check Out Why
Alexander Valtsev - at Seeking Alpha - Sat Mar 14, 2:10AM CDT

PCLN: 1,158.41 (+0.64)

The Zacks Analyst Blog Highlights: Coca-Cola, Kinder Morgan, Priceline Group, Berkshire Hathaway and Apple - Press Releases
Zacks Equity Research - Zacks Investment Research - Fri Mar 13, 8:30AM CDT
The Zacks Analyst Blog Highlights: Coca-Cola, Kinder Morgan, Priceline Group, Berkshire Hathaway and Apple
KMI: 40.49 (+0.57), KO: 40.14 (+0.23), AAPL: 124.24 (+0.65), BRK.A: 219,487.00 (+2,369.00), PCLN: 1,158.41 (+0.64)

Expedia Is Flying Too High For Comfort
Sneha Shah - at Seeking Alpha - Fri Mar 13, 7:09AM CDT

EXPE: 92.67 (+1.32), PCLN: 1,158.41 (+0.64)

Can Priceline Continue To Soar?
Abba's Aces - at Seeking Alpha - Fri Mar 13, 12:05AM CDT

PCLN: 1,158.41 (+0.64)

One Reason To Be Cautious On Priceline
Paulo Santos - at Seeking Alpha - Thu Mar 12, 4:03PM CDT

PCLN: 1,158.41 (+0.64)

Euro Collapse No Longer a Major Concern for US Companies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 2:12PM CDT
Certain US firms have a new strategy "Reverse Yankees" to offset the pressure from weaker euro.
KMI: 40.49 (+0.57), KO: 40.14 (+0.23), T: 33.00 (+0.24), BRK.A: 219,487.00 (+2,369.00), AAPL: 124.24 (+0.65), PCLN: 1,158.41 (+0.64)

Priceline Might Be Planning A Big Acquisition, Possibly Yelp!
Brian Nichols - at Seeking Alpha - Thu Mar 12, 12:42PM CDT

YELP: 46.06 (-0.39), PCLN: 1,158.41 (+0.64)

Priceline Prices Senior Notes Again; Moody's Rates as Baa1 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 12, 11:30AM CDT
The Priceline Group Inc. (PCLN) has again announced its intention to price Senior Notes in an underwritten public offering.
ABTL: 13.50 (+0.07), PETS: 15.77 (+0.05), GRPN: 7.77 (unch), PCLN: 1,158.41 (+0.64)

Priceline.com Reveals the Top 50 Most Popular Spring Break Destinations According to College Students
PR Newswire - Thu Mar 12, 9:21AM CDT
Every year spring break offers college students a much-needed respite from their late-night study sessions and an excuse to take a spontaneous getaway with friends. In fact, 73 percent of Americans between the ages of 18 and 24 say they are likely to take a last-minute getaway in 2015, according to a recent survey commissioned by the brand. In March, students are reserving more hotel rooms in Las Vegas, the most popular 2015 spring break destination, than anywhere else. Runner-up destinations include Orlando, New York City, Phoenix, and Orange County, according to actual hotel reservations made by college students on priceline.com.
PCLN: 1,158.41 (+0.64)

Which Travel Site Will Feel The Heat From Amazon Travel And Instant Booking?
Brian Wu - at Seeking Alpha - Wed Mar 11, 4:55PM CDT

AMZN: 372.47 (+1.89), TRIP: 82.87 (+0.35), EXPE: 92.67 (+1.32), OWW: 11.72 (+0.01), PCLN: 1,158.41 (+0.64)

Expedia Invests $270M in Decolar; Grows in Latin America - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Mar 11, 12:00PM CDT
In a bid to expand its exposure in the region, online travel-booking company, Expedia Inc. (EXPE) invested $270 million in Decolar.com.
EXPE: 92.67 (+1.32), GOOGL: 562.86 (+9.86), OWW: 11.72 (+0.01), PCLN: 1,158.41 (+0.64)

MakeMyTrip: A Good Way To Capitalize On Rising Consumerism And Mobile Penetration In India
Sneha Shah - at Seeking Alpha - Wed Mar 11, 9:39AM CDT

EXPE: 92.67 (+1.32), MMYT: 21.00 (+0.29), PCLN: 1,158.41 (+0.64)

Look for Shares of priceline.com to Potentially Rebound after Yesterday's 2.13% Sell Off
Comtex SmarTrend(R) - Tue Mar 10, 4:03PM CDT
priceline.com (NASDAQ

CLN) traded in a range yesterday that spanned from a low of $1,186.69 to a high of $1,203.99. Yesterday, the shares fell 2.1%, which took the trading range below the 3-day low of $1,202.00 on volume of 784,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
PCLN: 1,158.41 (+0.64)

Euro Pain Hits Stocks, But U.S. Multinationals Want the Last Laugh
Dan Caplinger, The Motley Fool - Motley Fool - Tue Mar 10, 10:26AM CDT
Source: Eric Chan via Flickr. The stock market opened sharply lower on Tuesday, with the Dow Jones Industrials falling almost 200 points as of 11:20 a.m. EDT and other major-market benchmarks falling in the neighborhood of 1%. Many market...
KO: 40.14 (+0.23), T: 33.00 (+0.24), PCLN: 1,158.41 (+0.64)

Priceline plans another debt offering
Seeking Alpha - at Seeking Alpha - Tue Mar 10, 8:16AM CDT

PCLN: 1,158.41 (+0.64)

Nasdaq 5000: 3 Undervalued Tech Stocks to Buy Now
Andrés Cardenal, The Motley Fool - Motley Fool - Tue Mar 10, 7:30AM CDT
The Nasdaq index made record highs last week, approaching the 5,000 level and breaking through the "dot-com bubble" highs of the year 2000. This could understandably generate some concerns among investors, and it's generally a good idea to be...
FB: 77.65 (-0.40), GOOGL: 562.86 (+9.86), GOOG: 555.84 (+8.52), AAPL: 124.24 (+0.65), PCLN: 1,158.41 (+0.64)

The Priceline Group Announces Proposed Public Offering of Senior Notes
PR Newswire - Tue Mar 10, 7:30AM CDT
The Priceline Group Inc. (Nasdaq: PCLN) announced today its intention to offer, subject to market and other conditions, Senior Notes in an underwritten public offering.
PCLN: 1,158.41 (+0.64)

InsiderInsights.com Daily Round Up 3/6/15: BK, OAS, GPC, CAPL
InsiderInsights - at Seeking Alpha - Sat Mar 07, 11:01AM CST

OCR: 76.68 (+0.95), GPC: 95.74 (+1.27), BRCM: 45.02 (+0.75), QTWO: 21.41 (+0.05), CB: 101.83 (+1.52), AMRI: 18.94 (+0.09), LKFN: 41.53 (+0.18), PCLN: 1,158.41 (+0.64), HTWO: 9.47 (+0.14), GGP: 30.03 (+0.38), ARMK: 32.32 (+0.10), CAPL: 33.82 (-0.39), ETFC: 28.14 (+0.16), TWTR: 46.36 (-0.30), BLMN: 24.69 (+0.13), GRPN: 7.77 (unch), BK: 40.99 (+0.05), IG: 8.14 (-0.03), OAS: 13.08 (-0.85), ALCO: 45.82 (-0.29)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

First-Time Homeowners: Unseen Pitfalls of Insurance

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Ris-Rez May Set New Standard in Relapsed SCLC

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Tam-Peli Steps Up in SCLC Battle: Trial Insights

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Trial Disappointment: No Significant Gains in NSCLC

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

GORGIE Unleashes Berry Burst: Target's New Drink Star

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

UWM Faces Class Action Deadline: Key Insights for Investors

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

PwC US and India Unite for Global Consultancy Powerhouse

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...